(NUVL) Nuvalent - Performance 3.8% in 12m

NUVL performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.

Performance Rating 47.20%
#11 in Peer-Group
Rel. Strength 44.27%
#4271 in Stock-Universe
Total Return 12m 3.77%
#59 in Peer-Group
Total Return 5y 331.63%
#4 in Peer-Group
P/E Value
P/E Trailing -
P/E Forward -
High / Low USD
52 Week High 112.17 USD
52 Week Low 59.32 USD
Sentiment Value
VRO Trend Strength +-100 77.03
Buy/Sell Signal +-5 -0.12
Support / Resistance Levels
Support
Resistance
12m Total Return: NUVL (3.8%) vs XBI (-11.1%)
Total Return of Nuvalent versus its related sector ETF XBI
5y Drawdown (Underwater) Chart
5 Year Drawdown / Underwater Chart for (NUVL) Nuvalent - Performance 3.8% in 12m

Top Performer in Biotechnology

Short Term Performance

Symbol 1w 1m 3m
NUVL 3.85% 5.23% 22.1%
RGC -20.0% -9.97% 1,445%
PROK 649% 386% 521%
ABVC -0.50% 138% 334%

Long Term Performance

Symbol 6m 12m 5y
NUVL 12.6% 3.77% 332%
DRUG -29.9% 2,484% -8.11%
RGC 0.0% 0.0% 5,238%
MNPR 43.5% 924% -6.95%

Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating

Symbol 1m 12m 5y P/E P/E Forward PEG EPS Stability EPS CAGR
GILD NASDAQ
Gilead Sciences
1.02% 61.8% 74.7% 23.5 14.1 0.23 28.3% -3.71%
UTHR NASDAQ
United Therapeutics
6.89% -8.76% 155% 12 11 1.43 74.6% 16.1%
AMGN NASDAQ
Amgen
1.19% -6.24% 38% 27.2 14.2 0.99 0.60% 41%
BIM PA
Biomerieux
-2.29% 26.9% -2.56% 32.7 25.8 1.55 -38.5% -25.1%
NBIX NASDAQ
Neurocrine Biosciences
7.48% -8.9% 5.85% 45.7 26.2 0.27 18.7% -34.3%
KMDA NASDAQ
Kamada
11.5% 27.6% -6.21% 27.6 22.4 0.9 68.9% 36.8%
PTCT NASDAQ
PTC Therapeutics
-4.47% 46.2% -8.05% 7.54 6.09 0.81 - 68%
ERF PA
Eurofins Scientific SE
1.64% 26.9% 19% 28.9 15.4 0.64 -62.1% -19.3%

Performance Comparison: NUVL vs XBI vs S&P 500

XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for NUVL
Total Return (including Dividends) NUVL XBI S&P 500
1 Month 5.23% 3.15% 4.01%
3 Months 22.08% 17.08% 17.14%
12 Months 3.77% -11.14% 13.46%
5 Years 331.63% -21.96% 112.73%

Trend Score (consistency of price movement) NUVL XBI S&P 500
1 Month 69.1% 52.1% 90.3%
3 Months 79.8% 79.4% 97.5%
12 Months -49.5% -87.4% 46.4%
5 Years 87.6% -52.1% 84%

Relative Strength (compared with Indexes) Rank in Peer Group vs. XBI vs. S&P 500
1 Month %th63.50 2.01% 1.17%
3 Month %th56.00 4.27% 4.22%
12 Month %th71.00 16.78% -8.54%
5 Years %th99.50 519.76% 188.20%

FAQs

Does Nuvalent (NUVL) outperform the market?

Yes, over the last 12 months NUVL made 3.77%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.14%. Over the last 3 months NUVL made 22.08%, while XBI made 17.08%.

Performance Comparison NUVL vs Indeces and Sectors

Above 0 means better perfomance compared to Symbol in this Timeframe

NUVL vs. Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY 3.4% 1.2% 4.7% -10%
US NASDAQ 100 QQQ 3.5% 1% 2.7% -10%
German DAX 40 DAX 3% 4% -7.4% -26%
Shanghai Shenzhen CSI 300 CSI 300 2.2% 0.7% 0.3% -15%
Hongkong Hang Seng HSI 2.5% 2.4% -17.3% -31%
India NIFTY 50 INDA 4.7% 6% 4.3% 7%
Brasil Bovespa EWZ 7.6% 5.9% -10.3% 2%

NUVL vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC 4.8% 3.5% 1.4% -20%
Consumer Discretionary XLY 2.5% 1.9% 12.4% -14%
Consumer Staples XLP 5.4% 5.4% 5.7% -4%
Energy XLE 0.4% 1.1% 12.3% 2%
Financial XLF 4.8% 2.6% 2.4% -22%
Health Care XLV 3.2% 5.2% 16.2% 10%
Industrial XLI 3% 0.8% -1.1% -20%
Materials XLB 2.7% 0.8% 4.1% -0%
Real Estate XLRE 3.6% 5.4% 6.2% -4%
Technology XLK 3.5% -1.4% -0.4% -7%
Utilities XLU 3.3% 2.6% 0.7% -16%
Aerospace & Defense XAR 2.7% -1.6% -15.3% -45%
Biotech XBI -0.3% 2.1% 15% 15%
Homebuilder XHB 0.3% -3.5% 11.3% 5%
Retail XRT 3.5% 2% 9.6% -3%

NUVL vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO 2.8% 1.93% 18.6% 8%
Natural Gas UNG 5.1% 11.7% 30.7% 6%
Gold GLD 3.3% 5% -13.2% -35%
Silver SLV -0.9% -1.1% -17.3% -18%
Copper CPER -6.9% -9.7% -14.8% -20%

NUVL vs. Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT 4.3% 5.3% 10% 8%
iShares High Yield Corp. Bond HYG 3.9% 4.1% 7.7% -5%